Rheumon Gel 1 g of gel contains 50 mg of etofenamate. For use in adults.

Similar documents
PACKAGE LEAFLET: INFORMATION FOR THE USER. Clindamycin 300 mg Capsules Clindamycin (as hydrochloride)

Consumer Medicine Information. Topical Cream Clotrimazole 10 mg/g & Hydrocortisone 10 mg/g

Daktacort 2% / 1% w/w cream

Package leaflet: Information for the patient. Epiduo 0.3% / 2.5% gel adapalene / benzoyl peroxide

What is in this leaflet 1. What Dalacin Cream is and what it is used for

ISOTREX GEL Isotretinoin 0.05% w/w

Eumovate Cream clobetasone butyrate

PATIENT INFORMATION LEAFLET. Timodine Cream

DP Fusidic Acid Cream

Package leaflet: Information for the user. Acnatac 10 mg/g mg/g gel clindamycin and tretinoin

Package leaflet: Information for the user. Tactuo 0.1% / 2.5% gel Adapalene/Benzoyl Peroxide

PATIENT INFORMATION LEAFLET. Hydromol HC Intensive Hydrocortisone and urea

Retin-A 0.05% w/w cream

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 5 g and pre-medication packs) lidocaine 2.5%, prilocaine 2.5%

Package leaflet: Information for the user. ZORAC 0.05% gel ZORAC 0.1% gel. Tazarotene

ClobaDerm 0.05% w/w Cream & Ointment (clobetasol propionate)

PACKAGE LEAFLET. EN Elastoplast Heat Plaster 11 mg January

ClobaDerm 500 micrograms/g Cream & Ointment (clobetasol propionate)

Hydrozole Cream Hydrocortisone (microfine) 1% w/w and clotrimazole 1% w/w

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. TRAVATAN Z Travoprost Ophthalmic Solution

DUAL ACTION LOGO. Quinoderm 10% / 0.5% w/w Cream Benzoyl Peroxide, hydrous / Potassium Hydroxyquinoline Sulfate

PACKAGE LEAFLET: INFORMATION FOR THE USER. TRAVATAN 40 micrograms/ml eye drops, solution Travoprost

ACETOCAUSTIN 0,5 ml, Cutaneous solution

PATIENT INFORMATION LEAFLET. AMETOP GEL 4% w/w Tetracaine

PATIENT INFORMATION LEAFLET. Alphaderm 1% & 10% w/w Cream hydrocortisone and urea

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 30 g surgical packs) lidocaine 2.5%, prilocaine 2.5%

CONSUMER MEDICINE INFORMATION

EMLA. Prilocaine 2.5%, Lignocaine 2.5% CONSUMER MEDICINE INFORMATION

PACKAGE LEAFLET: INFORMATION FOR THE USER. Schollmed Once Weekly Fungal Nail Treatment 5% w/v Medicated Nail Lacquer

PACKAGE LEAFLET: INFORMATION FOR THE USER. Isotrex Gel isotretinoin 0.05% w/w

Dermovate Scalp Application clobetasol propionate

Package leaflet: Information for the user Rogaine 50 mg/g, cutaneous foam. minoxidil

Hydroform Cream 1% Hydrocortisone (microfine) 1% w/w and clioquinol 1% w/ w

Dermovate Ointment clobetasol propionate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Vaniqa 11.5% cream Eflornithine

Package Leaflet: Information for the User

Eumovate Ointment clobetasone butyrate

Dermovate Ointment clobetasol propionate

1 What Gyno-Daktarin cream is and what it is used for

Dalacin V Cream Clindamycin phosphate

Betnovate Scalp Application betamethasone valerate. 1 What Betnovate is and what it is used for. 2 What you need to know before you use Betnovate

Dermovate Scalp Application clobetasol propionate

Package leaflet: Information for the patient. Onytec 80 mg/g medicated nail lacquer For adults Ciclopirox

SIGMACORT cream and ointment

Package leaflet: Information for the user. Trimovate Cream clobetasone 17-butyrate, calcium oxytetracycline and nystatin

Package Leaflet Information for the User ILUBE 5% w/v eye drops, solution. Acetylcysteine

Occlusal 26%w/w cutaneous solution salicylic acid

Package leaflet: Information for the patient. Clindamycin ABR 150 mg capsules, hard. Clindamycin ABR 300 mg capsules, hard

WOMEN'S Regaine EXTRA STRENGTH

Package leaflet: Information for the user. Versatis 700 mg medicated plaster Lidocaine

PATIENT INFORMATION LEAFLET PUVA TREATMENT. using. Puvasoralen 1.2% Bath Lotion (8-methoxypsoralen)

Package leaflet: Information for the patient. Duac Once Daily 10mg/g + 50mg/g Gel clindamycin + anhydrous benzoyl peroxide

Hair Loss Treatment Regular Strength (Minoxidil)

O N C E A DAY. In this leaflet FOR WOMEN

EUMOVATE Clobetasone butyrate 0.05% w/w cream

Information PROPECIA Finasteride 1mg Tablet

clindamycin (as phosphate) 1% w/w and tretinoin 0.025% w/w; (klin-da-mye-sin fos-fate) and (tret- i-noin) CONSUMER MEDICINE INFORMATION

STELARA INJECTION. What is in this leaflet. Before you use STELARA. What STELARA is used for. Consumer Medicine Information

STELARA INJECTION Ustekinumab (rmc) Consumer Medicine Information

Package leaflet: Information for the user. Regaine for Men Extra Strength Scalp Foam 5% w/w cutaneous foam. Minoxidil

Package leaflet: Information for the patient SAFLUTAN 15 micrograms/ml Eye drops, solution in single dose-container. Tafluprost

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

Package leaflet: Information for the user. Vaniqa 11.5% cream Eflornithine

INFORMATION ABOUT YOUR TREATMENT

scalp solution 5% w/v minoxidil cutaneous solution to be applied to the scalp

Package leaflet: Information for the user EMLA Cream 5% (for 30 g surgical packs) lidocaine/prilocaine

Package leaflet: Information for the user. Fredomat 40 microgram/ml oogdruppels, oplossing. Travoprost

Ego DermAid 1% cream Hydrocortisone 1 % w/w

POLYTAR Plus Liquid PRODUCT INFORMATION. Polytar Plus Liquid medicated scalp cleanser, contains coal tar solution.

PENTAMYCETIN is an antibiotic that: Stops the growth of bacteria Kills bacteria

Patient Information Leaflet. Dermal Filler

For the use only of a Registered Medical Practitioner or a Hospital or a Laboratory OILATUM EMOLLIENT. Light Liquid Paraffin Emollient

Package leaflet: Information for the user. Travoprost Pharmathen 40 microgram/ml, oogdruppels, oplossing Travoprost

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

A guide for patients who have been prescribed Stelara

ARE YOU? PsA TREAT YOUR SYMPTOMS WITH FOUR DOSES A YEAR. RECOGNIZE THE FOUR SIGNS OF PsA.

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory DERMOCALM LOTION. Calamine and Light Liquid Paraffin Lotion

Psoralen Tablets (Methoxypsoralen)

Daivobet 50/500 gel Dye-vo-bet

The solution contains isopropyl alcohol 50% v/v, propylene glycol, and water.

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory BREVOXYL HYDROPHASE. Benzoyl Peroxide Cream IP

Laser Resurfacing Post Op

Frequently asked questions about. Scabies. From the Branch-Hillsdale-St. Joseph Community Health Agency

FACT SHEET: ISOTRETINOIN INFORMATION FOR PATIENTS

You and your scalp. Helpful hints and advice on treating Dry Scaly Scalp Conditions

v02 USER INFORMATION LEAFLET 5% w/v Cutaneous Solution Minoxidil for MEN AND WOMEN 139.7mm 69.85mm 69.85mm 130.2mm Inside Cover CELL SIZE 1mm

v MM 130.2MM FOR WOME N O N C E A D AY

Item/Package Details Size Item Bottle ph Shelf Life 1.0 oz/29.6 ml 1101 Lucite Matte Silver Pump months

Atopic Dermatitis (Eczema) Allergy and Immunology Awareness Program

Skin Allergy Testing Information

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory BREVOXYL CREAMY WASH. Benzoyl Peroxide Creamy Wash 4%

Wound care and treatment Burns (1st, 2nd and 3rd degree burns) Sunburn

Lichen Planus. Patient Information. Women and Children Gynaecology

Lichen Planus. Patient Information. Women & Children Gynaecology

2% w/v Cutaneous Solution Minoxidil PATIENT INFORMATION LEAFLET PANTONE 185 C. 120lpi 0degrees. Black 120lpi 0degrees. Varnish 120lpi 0degrees

MyStelara. For patients who have been prescribed Stelara

COPPERPEX GEL. The product for lips with herpes TOPICAL USE. Medical Device

Why should you self-care? How can my local pharmacist help? How your pharmacist can help

Scar management. Patient Information Service. Southend University Hospital NHS Foundation Trust. Rehabilitation department Hand therapy

Dermal Fillers Information Guide

Transcription:

New Zealand Consumer Medicine Information Rheumon Gel 1 g of gel contains 50 mg of etofenamate. For use in adults. Read all of this leaflet carefully before you start using this medicine. This medicine is available without prescription. However, you still need to use Rheumon Gel carefully to get the best results from it. Keep this leaflet. You may need to read it again. Ask your pharmacist if you need more information or advice. You must contact a doctor if your symptoms worsen or do not improve after three days. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. In this leaflet: 1. What Rheumon Gel is and what it is used for 2. Before you use Rheumon Gel 3. How to use Rheumon Gel 4. Possible side effects 5. How to store Rheumon Gel 6. Further information 1. WHAT RHEUMON GEL IS AND WHAT IT IS USED FOR Rheumon Gel is a medicine for external, local application. Etofenamate, the active substance in Rheumon Gel, belongs to the group of the nonsteroidal (cortisone-free) anti-rheumatics (rheumatism cure) and has anti-inflammatory (antiphlogistic) and pain-relieving (analgesic) properties. Uses For the external supportive symptomatic treatment of pain: caused by acute strains, sprains or bruises in the limbs after blunt injuries such as sports injuries; in soft tissue near a joint (e.g. bursa, tendon, cord and joint capsule) in cases of arthrosis of the knee. Do not use Rheumon Gel for longer than 3 days without checking with your doctor. 2. BEFORE YOU USE RHEUMON GEL Do not use Rheumon Gel,

if you are allergic (hypersensitive) to etofenamate, flufenamic acid, any of the other ingredients of Rheumon Gel or to any other pain reliever or rheumatic cure (nonsteroidal anti-inflammatory agents); on open injuries, inflammations or infections of the skin as well as on skin eczema or on mucous membranes. in the last trimester of pregnancy. in children and adolescents. Take special care with Rheumon Gel: if you have asthma, hay fever, swelling of the mucous membranes of the nose (socalled nasal adenoids), chronic obstructive airway diseases or chronic airway infections, especially if they are combined with hay-fever-like manifestations, if you develop hypersensitivity reactions, such as skin reactions, itching or nettle rash after use of other substances. Rheumon Gel must not be used in children and adolescents since no adequate experience for this age group is available. Take care that children do not touch with their hands skin parts rubbed with this medication. Take care that Rheumon Gel does not get in contact with the eyes. Using Rheumon Gel with other medicines: No interactions have been reported up to now after use of Rheumon Gel as directed. Nevertheless, please tell your doctor if you are taking or have recently taken any other medicines. Pregnancy and breast-feeding Pregnancy During the first and second trimester of pregnancy, you should use Rheumon Gel only after having consulted your doctor. Rheumon Gel must not be used during the last trimester as an increased risk of complications for mother and child cannot be ruled out. Breast-feeding period Due to the fact that etofenamate passes into the breast milk to a small extent, prolonged use of Rheumon Gel by breastfeeding mothers should be avoided, if possible, and the daily dose (see Section 3) must not be exceeded. In order to avoid absorption by the sucking baby, breastfeeding mothers must not use this medicinal product in the region of their breasts. Important information about some of the ingredients of Rheumon Gel For further ingredients, refer to Section 6, "Further Information".

3. HOW TO USE RHEUMON GEL Always use Rheumon Gel exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. Unless otherwise prescribed by your doctor, the usual dose is: Depending on the size of the painful areas, apply an about 5-10 cm long ribbon (equivalent to about 3 g of Rheumon Gel and 75-150 mg of etofenamate) three times a day in a thin layer. For treatment of blunt injuries with Rheumon Gel, the maximum daily dose is 9 g of gel, equivalent to 450 mg of etofenamate. Only for external application to the skin. Do not ingest. Apply Rheumon Gel in a thin layer on the affected parts of the body and gently rub into the skin. Before applying a dressing, Rheumon Gel should be left for a few minutes to dry on the skin. The application of an occlusive dressing (plastic film cover) is not recommended. Usually treatment for one week is sufficient. Therapeutic benefit of a longer use has not been verified. You should avoid using Rheumon Gel for a long period or applying it over a large area. Please tell your doctor or pharmacist if you have the impression that the activity of Rheumon Gel is either too strong or too weak. If you used more Rheumon Gel than you should If you have exceeded the recommended dose on the skin, remove the gel and rinse with water. If much too big portions have been used or after inadvertent intake of Rheumon Gel, the doctor must be informed. 4. POSSIBLE SIDE EFFECTS Like all medicines, Rheumon Gel can cause side effects. Evaluation of the side effects is based on the following frequency information: Very common: Less than 10% of treated patients Common: Between 1% to 10% of treated patients Uncommon: Between 0.1% to 1% of treated patients Rare Between 0.01% to 0.1% of treated patients Very rare Less than 0.01% of treated patients Not known (Frequency cannot be estimated from the available data)

Uncommonly, local skin reactions such as reddening of the skin, itching, burning sensation, skin rash, sometimes with pimples or hives, can develop. In rare cases, Rheumon Gel can cause hypersensitivity reactions or local allergic reactions (contact dermatitis). If Rheumon Gel is applied on large skin surface areas and over a longer period of time, development of side effects associated with systemic absorption of the medicine may occur. Headaches, dizziness or stomach discomfort can occur if too much Rheumon Gel is applied over large areas of the body. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. Which counter-measures must be taken for side effects? When you stop using this medicine, usually the skin reactions will promptly disappear. Therefore, no other specific measures need to be taken. 5. HOW TO STORE RHEUMON GEL Keep out of the reach and sight of children. Do not use this medicine after the expiry date which is stated on the carton and on the label after Use before. Storage conditions Store below 25 C. Information concerning in-use shelf-life After first opening of the tube, the product has a shelf life of 12 weeks. 6. FURTHER INFORMATION What Rheumon Gel contains: The active substance is: Etofenamate The other ingredients are: Alpha-[hexadecyl,(Z)-octadec-9-en-1-yl]-ω-hydroxypoly(oxyethylene)-8, Macrogol 400, sodium hydroxide, Carbomer, propan-2-ol, propylene glycol and purified water. Rheumon Gel can cause discolouration or surface damage if it gets in contact with polished furniture or synthetic surfaces. If necessary, wash your hands after applying or avoid the contact with such objects. How Rheumon Gel looks like and contents of the pack Rheumon Gel is a clear colorless gel and available in original packs containing 50 g of gel.

Distributed in NZ by: Mylan New Zealand Limited PO Box 11183 Ellerslie, Auckland New Zealand Telephone: 0800 168 169 Date of preparation: 19 December 2017